Literature DB >> 28980818

Acid-Activatable Theranostic Unimolecular Micelles Composed of Amphiphilic Star-like Polymeric Prodrug with High Drug Loading for Enhanced Cancer Therapy.

Xiaoxiao Shi1,2, Meili Hou1,2, Shuang Bai1,2, Xiaoqian Ma1,2, Yong-E Gao1,2, Bo Xiao1,3, Peng Xue1,2, Yuejun Kang1,2, Zhigang Xu1,2, Chang Ming Li1,2.   

Abstract

Stimuli-responsive nanomedicine with theranostic functionalities with reduced side-effects has attracted growing attention, although there are some major obstacles to overcome before clinical applications. Herein, we present an acid-activatable theranostic unimolecular micelles based on amphiphilic star-like polymeric prodrug to systematically address typical existing issues. This smart polymeric prodrug has a preferable size of about 35 nm and strong micellar stability in aqueous solution, which is beneficial to long-term blood circulation and efficient extravasation from tumoral vessels. Remarkably, the polymeric prodrug has a high drug loading rate up to 53.1 wt%, which induces considerably higher cytotoxicity against tumor cells (HeLa cells and MCF-7 cells) than normal cells (HUVEC cells) suggesting a spontaneous tumor-specific targeting capability. Moreover, the polymeric prodrug can serve as a fluorescent nanoprobe activated by the acidic microenvironment in tumor cells, which can be used as a promising platform for tumor diagnosis. The superior antitumor effect in this in vitro study demonstrates the potential of this prodrug as a promising platform for drug delivery and cancer therapy.

Entities:  

Keywords:  acid-activatable; cancer therapy; drug delivery; polymeric prodrug; unimolecular micelles

Mesh:

Substances:

Year:  2017        PMID: 28980818     DOI: 10.1021/acs.molpharmaceut.7b00704

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  3 in total

Review 1.  Nanoparticulation of Prodrug into Medicines for Cancer Therapy.

Authors:  Yuezhou Zhang; Huaguang Cui; Ruiqi Zhang; Hongbo Zhang; Wei Huang
Journal:  Adv Sci (Weinh)       Date:  2021-07-29       Impact factor: 16.806

Review 2.  Endogenous pH-responsive nanoparticles with programmable size changes for targeted tumor therapy and imaging applications.

Authors:  Wei Wu; Li Luo; Yi Wang; Qi Wu; Han-Bin Dai; Jian-Shu Li; Colm Durkan; Nan Wang; Gui-Xue Wang
Journal:  Theranostics       Date:  2018-04-30       Impact factor: 11.556

3.  The design and synthesis of dextran-doxorubicin prodrug-based pH-sensitive drug delivery system for improving chemotherapy efficacy.

Authors:  Xiaoli Zhang; Tian Zhang; Xianbin Ma; Yajun Wang; Yi Lu; Die Jia; Xiaohua Huang; Jiucun Chen; Zhigang Xu; Feiqiu Wen
Journal:  Asian J Pharm Sci       Date:  2019-11-06       Impact factor: 6.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.